The unique reproductive concerns of young women with breast cancer

Kathryn J Ruddy, Ann H. Partridge

Research output: Chapter in Book/Report/Conference proceedingChapter

9 Citations (Scopus)

Abstract

Many young women with breast cancer are interested in having a biologic child in the future. However, adjuvant chemotherapy can cause ovarian toxicity and fertility naturally declines due to ovarian aging that occurs during the recommended five years of treatment with adjuvant hormonal therapy. Decisions about fertility after breast cancer are further complicated by concerns about the safety of fertility preservation and subsequent pregnancy after breast cancer, despite limited available data for safety. At the present time, the most reliable fertility preservation method for breast cancer patients is embryo cryopreservation prior to treatment, although alternative options exist. In an effort to allow women to pursue fertility preservation if warranted and avoid excessive treatment delay, it is important to consider fertility concerns early in the care of young women with breast cancer.

Original languageEnglish (US)
Title of host publicationAdvances in Experimental Medicine and Biology
Pages77-87
Number of pages11
Volume732
DOIs
StatePublished - 2012
Externally publishedYes

Publication series

NameAdvances in Experimental Medicine and Biology
Volume732
ISSN (Print)00652598

Fingerprint

Fertility Preservation
Breast Neoplasms
Chemotherapy
Fertility
Toxicity
Aging of materials
Safety
Cryopreservation
Therapeutics
Adjuvant Chemotherapy
Embryonic Structures
Pregnancy

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)

Cite this

Ruddy, K. J., & Partridge, A. H. (2012). The unique reproductive concerns of young women with breast cancer. In Advances in Experimental Medicine and Biology (Vol. 732, pp. 77-87). (Advances in Experimental Medicine and Biology; Vol. 732). https://doi.org/10.1007/978-94-007-2492-1_6

The unique reproductive concerns of young women with breast cancer. / Ruddy, Kathryn J; Partridge, Ann H.

Advances in Experimental Medicine and Biology. Vol. 732 2012. p. 77-87 (Advances in Experimental Medicine and Biology; Vol. 732).

Research output: Chapter in Book/Report/Conference proceedingChapter

Ruddy, KJ & Partridge, AH 2012, The unique reproductive concerns of young women with breast cancer. in Advances in Experimental Medicine and Biology. vol. 732, Advances in Experimental Medicine and Biology, vol. 732, pp. 77-87. https://doi.org/10.1007/978-94-007-2492-1_6
Ruddy KJ, Partridge AH. The unique reproductive concerns of young women with breast cancer. In Advances in Experimental Medicine and Biology. Vol. 732. 2012. p. 77-87. (Advances in Experimental Medicine and Biology). https://doi.org/10.1007/978-94-007-2492-1_6
Ruddy, Kathryn J ; Partridge, Ann H. / The unique reproductive concerns of young women with breast cancer. Advances in Experimental Medicine and Biology. Vol. 732 2012. pp. 77-87 (Advances in Experimental Medicine and Biology).
@inbook{1673a440258045ba867c07138acb6c76,
title = "The unique reproductive concerns of young women with breast cancer",
abstract = "Many young women with breast cancer are interested in having a biologic child in the future. However, adjuvant chemotherapy can cause ovarian toxicity and fertility naturally declines due to ovarian aging that occurs during the recommended five years of treatment with adjuvant hormonal therapy. Decisions about fertility after breast cancer are further complicated by concerns about the safety of fertility preservation and subsequent pregnancy after breast cancer, despite limited available data for safety. At the present time, the most reliable fertility preservation method for breast cancer patients is embryo cryopreservation prior to treatment, although alternative options exist. In an effort to allow women to pursue fertility preservation if warranted and avoid excessive treatment delay, it is important to consider fertility concerns early in the care of young women with breast cancer.",
author = "Ruddy, {Kathryn J} and Partridge, {Ann H.}",
year = "2012",
doi = "10.1007/978-94-007-2492-1_6",
language = "English (US)",
isbn = "9789400724914",
volume = "732",
series = "Advances in Experimental Medicine and Biology",
pages = "77--87",
booktitle = "Advances in Experimental Medicine and Biology",

}

TY - CHAP

T1 - The unique reproductive concerns of young women with breast cancer

AU - Ruddy, Kathryn J

AU - Partridge, Ann H.

PY - 2012

Y1 - 2012

N2 - Many young women with breast cancer are interested in having a biologic child in the future. However, adjuvant chemotherapy can cause ovarian toxicity and fertility naturally declines due to ovarian aging that occurs during the recommended five years of treatment with adjuvant hormonal therapy. Decisions about fertility after breast cancer are further complicated by concerns about the safety of fertility preservation and subsequent pregnancy after breast cancer, despite limited available data for safety. At the present time, the most reliable fertility preservation method for breast cancer patients is embryo cryopreservation prior to treatment, although alternative options exist. In an effort to allow women to pursue fertility preservation if warranted and avoid excessive treatment delay, it is important to consider fertility concerns early in the care of young women with breast cancer.

AB - Many young women with breast cancer are interested in having a biologic child in the future. However, adjuvant chemotherapy can cause ovarian toxicity and fertility naturally declines due to ovarian aging that occurs during the recommended five years of treatment with adjuvant hormonal therapy. Decisions about fertility after breast cancer are further complicated by concerns about the safety of fertility preservation and subsequent pregnancy after breast cancer, despite limited available data for safety. At the present time, the most reliable fertility preservation method for breast cancer patients is embryo cryopreservation prior to treatment, although alternative options exist. In an effort to allow women to pursue fertility preservation if warranted and avoid excessive treatment delay, it is important to consider fertility concerns early in the care of young women with breast cancer.

UR - http://www.scopus.com/inward/record.url?scp=84856275114&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84856275114&partnerID=8YFLogxK

U2 - 10.1007/978-94-007-2492-1_6

DO - 10.1007/978-94-007-2492-1_6

M3 - Chapter

C2 - 22210253

AN - SCOPUS:84856275114

SN - 9789400724914

VL - 732

T3 - Advances in Experimental Medicine and Biology

SP - 77

EP - 87

BT - Advances in Experimental Medicine and Biology

ER -